循环脂肪酸与2型糖尿病遗传易感性:基因-营养素交互作用分析
基于英国生物银行95,854名参与者(2006-2010年入组,随访至2020年底),平均随访11.6年共记录3,052例2型糖尿病。血浆饱和脂肪酸和单不饱和脂肪酸与2型糖尿病风险正相关,多不饱和脂肪酸(包括n-6和n-3)与风险负相关;循环单不饱和脂肪酸和n-3多不饱和脂肪酸与2型糖尿病遗传易感性及脂肪酸相关变异存在显著交互作用。
要点
- 血浆饱和脂肪酸和单不饱和脂肪酸浓度与2型糖尿病风险正相关。
- 血浆多不饱和脂肪酸、n-6多不饱和脂肪酸和n-3多不饱和脂肪酸与2型糖尿病风险负相关。
- 循环单不饱和脂肪酸和n-3多不饱和脂肪酸与2型糖尿病遗传易感性存在显著交互作用。
核心结论
- 血浆饱和脂肪酸和单不饱和脂肪酸浓度与较高的2型糖尿病风险相关,而血浆多不饱和脂肪酸及n-6和n-3多不饱和脂肪酸与较低风险相关。
- 循环单不饱和脂肪酸和n-3多不饱和脂肪酸与2型糖尿病遗传易感性及脂肪酸相关变异存在显著交互作用。
研究设计与样本
- 研究纳入英国生物银行95,854名具有完整血浆脂肪酸数据的参与者,入组时间为2006年至2010年,随访至2020年底。
- 血浆饱和脂肪酸、单不饱和脂肪酸和多不饱和脂肪酸浓度通过高通量核磁共振生物标志物分析平台检测。
- 遗传风险评分基于424个与2型糖尿病相关的变异计算,并基于2型糖尿病位点的稳健聚类计算通路特异性遗传风险评分。
主要发现
- 平均随访11.6年后,共记录3,052例2型糖尿病。
- 校正主要风险因素后,每增加1个标准差,2型糖尿病风险比(95%CI)为:饱和脂肪酸1.03(1.02-1.04),单不饱和脂肪酸1.03(1.02-1.05),多不饱和脂肪酸0.62(0.56-0.68),n-6多不饱和脂肪酸0.67(0.61-0.73),n-3多不饱和脂肪酸0.90(0.85-0.95),n-6与n-3比值1.01(0.98-1.04)。
- 血浆单不饱和脂肪酸与总体遗传风险评分及胰岛素原和肝脏/脂质簇遗传风险评分对2型糖尿病风险存在显著交互作用。
- n-3多不饱和脂肪酸与2型糖尿病风险的保护性关联在肥胖遗传风险评分较高(交互作用P=0.040)和肝脏/脂质遗传风险评分较高(交互作用P=0.012)的个体中较弱。
- 血浆n-3多不饱和脂肪酸浓度升高与2型糖尿病风险降低的关联在携带更多二十二碳五烯酸相关等位基因的参与者中更强(交互作用P=0.007)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the relationship of circulating fatty acids (FA) with risk of type 2 diabetes (T2D) and potential interactions with genetic risk. RESEARCH DESIGN AND METHODS: A total of 95,854 participants with complete data on plasma FA from the UK Biobank were enrolled between 2006 and 2010 and were followed up to the end of 2020. Plasma concentrations of saturated fatty acids (SFA), monounsaturated fatty acids (MUFA), and polyunsaturated fatty acids (PUFA) were analyzed by a high-throughput nuclear magnetic resonance-based biomarker profiling platform. The genetic risk scores (GRS) were calculated on the basis of 424 variants associated with T2D. Pathway-specific GRS were calculated based on robust clusters of T2D loci. RESULTS: There were 3,052 instances of T2D documented after an average follow-up of 11.6 years. Plasma concentrations of SFA and MUFA were positively associated with T2D risk, while plasma PUFA were inversely associated. After adjustment for major risk factors, hazard ratios (95% CI) of T2D for 1-SD increment were 1.03 (1.02-1.04) for SFA, 1.03 (1.02-1.05) for MUFA, 0.62 (0.56-0.68) for PUFA, 0.67 (0.61-0.73) for n-6 PUFA, 0.90 (0.85-0.95) for n-3 PUFA, and 1.01 (0.98-1.04) for n-6-to-n-3 ratio. Plasma MUFA had significant interactions with the overall GRS and GRS for proinsulin and liver/lipid clusters on T2D risk. The protective associations of n-3 PUFA with T2D risk were weaker among individuals with higher obesity GRS (P interaction = 0.040) and liver/lipid GRS (P interaction = 0.012). Additionally, increased plasma n-3 PUFA concentration was associated with more reductions in T2D risk among participants carrying more docosapentaenoic acid-associated alleles (P interaction = 0.007). CONCLUSIONS: Plasma concentrations of SFA and MUFA were associated with a higher T2D risk, whereas plasma PUFA and n-6 and n-3 PUFA were related to a lower risk. Circulating MUFA and n-3 PUFA had significant interactions with genetic predisposition to T2D and FA-associated variants.
引用
- Zhuang P, Liu X, Li Y, et al. Circulating Fatty Acids and Genetic Predisposition to Type 2 Diabetes: Gene-Nutrient Interaction Analysis. Diabetes Care. 2022. PMID: 35089324. doi:10.2337/dc21-2048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。